Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature
Abstract Background First- and second-generation anti-epithelial growth factor receptor tyrosine kinase inhibitors have shown great efficacy in the treatment of advanced adenocarcinoma with epithelial growth factor receptor mutations, but this efficacy is limited by certain resistance mechanisms, in...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2024-08-01
|
| Serie: | Journal of Medical Case Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13256-024-04706-w |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|